IPHARMACIST LIMITED

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
16 MUIRHEAD COURT BAILLIESTON GLASGOW UNITED KINGDOM G69 7EP Copied!

Latest financial results as of 15 November 2025
Cash in bank
£2.07k
Current assets
£12.82k
Current creditors
£723
Shareholders funds
£15.03k
View full financial accounts

Company number
SC513498 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
TOTAL EXEMPTION FULL
Incorporated on
19 August 2015
Accounts

Latest annual accounts were to 31 August 2019

Next annual accounts are due by 31 May 2021

Company financial year end is on 31 August 2026

Confirmation statement

Latest confirmation statement statement dated 18 August 2020

Next statement due by 1 September 2021

Nature of business (SIC)

86900 - Other human health activities

Latest company documents
DateDescription
25/08/2025 August 2020 CONFIRMATION STATEMENT MADE ON 18/08/20, NO UPDATES

View Document

25/05/2025 May 2020 31/08/19 TOTAL EXEMPTION FULL

View Document

31/08/1931 August 2019 Annual accounts for year ending 31 Aug 2019

View Accounts

29/08/1929 August 2019 CONFIRMATION STATEMENT MADE ON 18/08/19, NO UPDATES

View Document

30/05/1930 May 2019 31/08/18 TOTAL EXEMPTION FULL

View Document

View all company documents
AI-Powered Analysis for IPHARMACIST LIMITED

Get instant insights with Claude AI. Ask questions like:

  • "Is IPHARMACIST LIMITED financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about IPHARMACIST LIMITED:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company